Literature DB >> 33810707

COVID-19 second wave mortality in Europe and the United States.

Nick James1, Max Menzies2, Peter Radchenko3.   

Abstract

This paper introduces new methods to analyze the changing progression of COVID-19 cases to deaths in different waves of the pandemic. First, an algorithmic approach partitions each country or state's COVID-19 time series into a first wave and subsequent period. Next, offsets between case and death time series are learned for each country via a normalized inner product. Combining these with additional calculations, we can determine which countries have most substantially reduced the mortality rate of COVID-19. Finally, our paper identifies similarities in the trajectories of cases and deaths for European countries and U.S. states. Our analysis refines the popular conception that the mortality rate has greatly decreased throughout Europe during its second wave of COVID-19; instead, we demonstrate substantial heterogeneity throughout Europe and the U.S. The Netherlands exhibited the largest reduction of mortality, a factor of 16, followed by Denmark, France, Belgium, and other Western European countries, greater than both Eastern European countries and U.S. states. Some structural similarity is observed between Europe and the United States, in which Northeastern states have been the most successful in the country. Such analysis may help European countries learn from each other's experiences and differing successes to develop the best policies to combat COVID-19 as a collective unit.

Entities:  

Mesh:

Year:  2021        PMID: 33810707     DOI: 10.1063/5.0041569

Source DB:  PubMed          Journal:  Chaos        ISSN: 1054-1500            Impact factor:   3.642


  26 in total

1.  COVID-19 Pandemic Waves and Mortality Among Patients on Kidney Replacement Therapy.

Authors:  Priya Vart; Kitty J Jager; Miha Arnol; Raphaël Duivenvoorden; Casper F M Franssen; Marc Groeneveld; Marc H Hemmelder; Fanny Lepeytre; Thomas Malfait; Karsten Midtvedt; Sandip Mitra; Carme Facundo; Marlies Noordzij; Carlos C Reina; Seda Safak; Nestor Toapanta; Luuk B Hilbrands; Ron T Gansevoort
Journal:  Kidney Int Rep       Date:  2022-06-20

2.  Analyzing the GHSI puzzle of whether highly developed countries fared worse in COVID-19.

Authors:  Sofija Markovic; Igor Salom; Andjela Rodic; Marko Djordjevic
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

3.  The impact of long-term non-pharmaceutical interventions on COVID-19 epidemic dynamics and control: the value and limitations of early models.

Authors:  Marissa L Childs; Morgan P Kain; Mallory J Harris; Devin Kirk; Lisa Couper; Nicole Nova; Isabel Delwel; Jacob Ritchie; Alexander D Becker; Erin A Mordecai
Journal:  Proc Biol Sci       Date:  2021-08-25       Impact factor: 5.349

4.  COVID-19 Propagation Model Based on Economic Development and Interventions.

Authors:  Fuzhong Nian; Yayong Shi; Jun Cao
Journal:  Wirel Pers Commun       Date:  2021-08-18       Impact factor: 1.671

5.  Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain.

Authors:  Albert Roso-Llorach; Xavier Serra-Picamal; Francesc X Cos; Meritxell Pallejà-Millán; Lourdes Mateu; Antoni Rosell; Benito Almirante; Jaume Ferrer; Mercè Gasa; Carlota Gudiol; Anna Maria Moreno; Jose Luís Morales-Rull; Maria Rexach; Gladis Sabater; Teresa Auguet; Francesc Vidal; Ana Lerida; Josep Rebull; Kamlesh Khunti; Josep M Argimon; Roger Paredes
Journal:  Glob Epidemiol       Date:  2022-01-07

6.  Estimating a continuously varying offset between multivariate time series with application to COVID-19 in the United States.

Authors:  Nick James; Max Menzies
Journal:  Eur Phys J Spec Top       Date:  2022-01-11       Impact factor: 2.891

7.  Collective correlations, dynamics, and behavioural inconsistencies of the cryptocurrency market over time.

Authors:  Nick James; Max Menzies
Journal:  Nonlinear Dyn       Date:  2022-01-03       Impact factor: 5.741

8.  Epidemiological comparison of the first and second waves of the COVID-19 pandemic in Nigeria, February 2020-April 2021.

Authors:  Oluwatosin Wuraola Akande; Kelly Osezele Elimian; Ehimario Igumbor; Lauryn Dunkwu; Chijioke Kaduru; Olubunmi Omowunmi Olopha; Dabri Olohije Ohanu; Lilian Nwozor; Emmanuel Agogo; Olusola Aruna; Muhammad Shakir Balogun; Olaolu Aderinola; Anthony Ahumibe; Chinedu Arinze; Sikiru Olanrewaju Badaru; William Nwachukwu; Augustine Olajide Dada; Cyril Erameh; Khadeejah Hamza; Tarik Benjamin Mohammed; Nnaemeka Ndodo; Celestina Obiekea; Chinenye Ofoegbunam; Oladipo Ogunbode; Cornelius Ohonsi; Ekaete Alice Tobin; Rimamdeyati Yashe; Afolabi Adekaiyaoja; Michael C Asuzu; Rosemary Ajuma Audu; Muhammad Bashir Bello; Shaibu Oricha Bello; Yusuf Yahaya Deeni; Yahya Disu; Gbenga Joseph; Chidiebere Ezeokafor; Zaiyad Garba Habib; Christian Ibeh; Ifeanyi Franklin Ike; Emem Iwara; Rejoice Kudirat Luka-Lawal; Geoffrey Namara; Tochi Okwor; Lois Olajide; Oluwafunke Olufemi Ilesanmi; Solomon Omonigho; Ferdinand Oyiri; Koubagnine Takpa; Nkem Usha Ugbogulu; Priscilla Ibekwe; John Oladejo; Elsie Ilori; Chinwe Lucia Ochu; Chikwe Ihekweazu
Journal:  BMJ Glob Health       Date:  2021-11

9.  Trends in COVID-19 prevalence and mortality: A year in review.

Authors:  Nick James; Max Menzies
Journal:  Physica D       Date:  2021-06-07       Impact factor: 2.300

10.  Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada.

Authors:  Sylvia H Hsu; Su-Hsin Chang; Cary P Gross; Shi-Yi Wang
Journal:  Int J Infect Dis       Date:  2021-07-01       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.